サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：エリスロポエチン製剤市場：タイプ別、製品別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1299748

エリスロポエチン製剤市場：タイプ別、製品別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Erythropoietin Drugs Market with COVID-19 Impact Analysis, By Type, By Product, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 358 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
エリスロポエチン製剤市場：タイプ別、製品別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 358 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

エリスロポエチン製剤の市場規模は2022年に70億810万米ドルとなり、2023年から2030年にかけてCAGR 10.5％で拡大

エリスロポエチン製剤市場-市場力学：

ESRD治療、抗レトロウイルス治療、化学療法によって引き起こされる貧血状態の有病率の増加は、エリスロポエチン市場の需要を増加させると予測される主な要因です。さらに、貧血治療以外にも、脳障害など、遺伝子組換えヒトエリスロポエチンにはいくつかの治療上の利点があります。さらに、エリスロポエチンを全身投与すると、血液脳関門を通過するため、神経可塑性が改善され、多くの脳疾患において認知機能が向上します。しかし、エリスロポエチン製剤のコストが上昇していることは、予測期間中の市場成長を抑制する主な要因のひとつです。

さらに、エリスロポエチン製剤の利点に関する認知度の向上、容易に利用可能な償還、エリスロポエチン・バイオシミラーの商業化動向の上昇が、EPO治療薬市場の成長を後押しすると予想されます。COVID-19パンデミックはエリスロポエチン製剤市場に好影響を与えました。医薬品の需要が増加し、さまざまな医療サービスの需要も増加しました。さらに、この医薬品は貧血治療に役立ち、COVID-19にも効くと言われています。

エリスロポエチン製剤市場-セグメンテーション分析：

世界のエリスロポエチン製剤市場は、タイプ、製品、用途、地域によって区分されます。

バイオ医薬品とバイオシミラーの2つに分類されます。バイオシミラー分野が市場を独占する可能性が高いです。強力な製品パイプライン、メーカーと病院間のパートナーシップの増加、開発研究資金の増加などがその理由です。

市場は製品によってエリスロポエチンとダルベポエチン-アルファの2つに分類されます。ダルベポエチン-アルファ製剤が市場を占有すると予想されます。これは部分的には、ダルベポエチン-アルファががんの化学療法を受けた患者に起こる貧血の治療に役立つためです。

市場は用途別に、がん、腎疾患、神経、その他の3つのカテゴリーに分類されます。予測期間中、最大の市場シェアを占めるのはがん分野と推定されます。がん患者は、アルコール、西洋的ライフスタイル、喫煙、食生活の乱れのために増加しています。そのため、がん分野の成長が促進されます。

エリスロポエチン製剤市場-競合情勢：

エリスロポエチン製剤に対する需要の増加は、世界の市場成長を促進します。さらに、市場プレーヤーは新製品の発売、パートナーシップ、ジョイントベンチャー、提携、地域的成長に注力しています。さらに、がん患者における貧血の増加がエリスロポエチン製剤市場の成長を後押ししています。さらに、市場プレーヤーが事業を強化・拡大するために用いる戦略には、研究開発費、M&A、販路開拓などがあります。例えば、2022年3月、Zydus Lifesciences社はOxemia（Desidustat）の新薬承認を取得しました。また、慢性腎臓病（CKD）に伴う貧血に対する初の経口治療薬として、インド医薬品監督庁（DCGI）から承認を取得しています。

研究の主な特徴

この調査レポートは、エリスロポエチン製剤市場の市場規模、CAGR、2022年を基準年とした推定・予測（2023-2030年）を提供しています。

この調査レポートは、さまざまなセグメント/国にわたる潜在的な成長機会を解明し、エリスロポエチン製剤市場の魅力的な投資提案マトリクスを解説しています。

全体的なレポートでは、新規投資機会、既存企業が直面する課題、エリスロポエチン製剤市場で持続するための成長要因を特定しています。

COVID-19がエリスロポエチン製剤の市場規模、予測、CAGR、市場力学に与える影響については、調査範囲で詳細に論じています。COVID後のエリスロポエチン製剤市場に関する詳細な洞察もカバーします。

本レポートのユーザーにエリスロポエチン製剤市場の包括的な見解を提供するために、エリスロポエチン製剤市場の競合情勢と主要イノベーター分析も含めています。

本調査では、市場規模、成長率、魅力度に基づいてすべての業界セグメントをベンチマークする成長見通しマッピング分析を網羅しています。

本レポートは、主要な市場参加者を取り上げた詳細な企業プロファイルを提供しており、エリスロポエチン製剤市場で事業を展開する企業の財務情報や戦略的イニシアチブを理解するのに役立ちます。

さらに、本レポートは、世界レベルおよび地域レベルでの市場に関与する主要参加者の重要な買収と合併、コラボレーションと合弁事業、新規立ち上げ、研究開発、地域展開も明らかにしています。

エリスロポエチン製剤の世界市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界の様々な利害関係者を対象としています。

目次

第1章 エリスロポエチン製剤市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 エリスロポエチン製剤の主要な市場動向

  • エリスロポエチン製剤市場促進要因
  • エリスロポエチン製剤市場抑制要因
  • エリスロポエチン製剤の市場機会
  • エリスロポエチン製剤市場の将来動向

第4章 エリスロポエチン製剤産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 エリスロポエチン製剤市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 エリスロポエチン製剤市場情勢

  • エリスロポエチン製剤市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 エリスロポエチン製剤市場- タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • 生物製剤
    • バイオシミラー

第8章 エリスロポエチン製剤市場- 製品別

  • 概要
    • 製品別セグメントシェア分析
    • エリスロポエチン
    • ダルベポエチンアルファ

第9章 エリスロポエチン製剤市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • がん
    • 腎臓病
    • 神経内科
    • その他

第10章 エリスロポエチン製剤市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米のエリスロポエチン製剤主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州のエリスロポエチン製剤主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域のエリスロポエチン製剤主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカのエリスロポエチン製剤主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカのエリスロポエチン製剤主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- エリスロポエチン製剤産業

  • 競合ダッシュボード
  • 企業プロファイル
    • AstraZeneca（UK）
    • Lupin（India）
    • Bristol-Myers Squibb Company（US）
    • Endo International plc（Ireland）
    • JCR Pharmaceuticals Co., Ltd（Japan）
    • Pfizer Inc（US）
    • Teva Pharmaceutical Industries Ltd（Israel）
    • Sun Pharmaceutical Industries Ltd（India）
    • Dr. Reddy's Laboratories Ltd（India）
    • Mylan NV（US）
    • Novartis AG（Switzerland）
    • Cipla Inc（India）
    • Shanghai Dahua Pharmaceutical Co., Ltd（China）

第12章 アナリストの全方位的展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Erythropoietin Drugs Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Erythropoietin Drugs Market, by Type2018-2030 (USD Million)
  • TABLE Erythropoietin Drugs Market: ProductSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Erythropoietin Drugs Market, by Product2018-2030 (USD Million)
  • TABLE Erythropoietin Drugs Market: Regional snapshot (2022)
  • TABLE Erythropoietin Drugs Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Erythropoietin Drugs Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Erythropoietin Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE EuropeErythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Erythropoietin Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022&2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product segment market share analysis, 2022&2030
  • FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022&2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Erythropoietin Drugs Market share and leading players, 2022
  • FIGURE Europe Erythropoietin Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Erythropoietin Drugs Market share and leading players, 2022
  • FIGURE Latin America Erythropoietin Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Erythropoietin Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Erythropoietin Drugs Market share analysis by country, 2022
  • FIGURE Germany Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE NetherlandsErythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE SwedenErythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE PolandErythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Erythropoietin Drugs Market share analysis by country, 2022
  • FIGURE India Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Erythropoietin Drugs Market share analysis by country, 2022
  • FIGURE Brazil Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE ColombiaErythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Erythropoietin Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Erythropoietin Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1338

REPORT HIGHLIGHT

Erythropoietin drugs market size was valued at USD 7,008.1 Million in 2022, expanding at a CAGR of 10.5% from 2023 to 2030.

Erythropoietin (EPO) is also known as hematopoietin, a glycoprotein hormone secreted from the kidneys that play an important role in the development of red blood cells (RBCs) in the bone by stimulating the bone marrow tissues. Additionally, a rise in RBC count increases the hemoglobin level in the bloodstream and delivers a sufficient amount of oxygen to every part of the body. Moreover, erythropoietin medications are largely used in the treatment of anemia caused by end-stage renal disease (ESRD) and dialysis procedures.

Erythropoietin Drugs Market- Market Dynamics:

The increasing prevalence of anemic conditions caused by ESRD treatment, antiretroviral treatment, and chemotherapy are major factors projected to increase the demand for the erythropoietin market. Additionally, besides treating anemia, several therapeutic advantages are associated with recombinant human erythropoietin such as brain disorders. Moreover, if erythropoietin is administered systematically, it passes the blood-brain barrier as a result improving neuroplasticity and rising cognitive functions in many brain disorders. However, the increasing cost of erythropoietin drugs is one of the major factors that could restrain the market growth during the forecast period.

Furthermore, increasing awareness regarding the advantages of erythropoietin therapeutics drugs, readily available reimbursements, and rising trends of commercialization for erythropoietin biosimilars are expected to boost the EPO drugs market growth. The COVID-19 pandemic had a positive impact on the erythropoietin drugs market. It increased the demand for medicines and also increased the demand for various medical services. Additionally, the drug is helpful in anemia treatment and works against COVID-19.

Erythropoietin Drugs Market- Segmentation Analysis:

The global erythropoietin drugs market is segmented on the basis of type, product, application, and region.

The market is divided into two categories based on type: biologics and biosimilars. The biosimilars sector is likely to dominate the market. Due to the strong product pipeline, an increasing partnership among manufacturers & hospitals, and rising funds for development & research.

The market is divided into two categories based on product: erythropoietin and darbepoetin-alfa. The darbepoetin-alfa sector is expected to possess the market. This is partially due to darbepoetin-alfa helping in treating anemia that occurs in a patient who received chemotherapy for cancer.

The market is divided into three categories based on application: cancer, renal diseases, neurology, and others. The cancer sector is estimated to hold the largest market share during the forecast period. Cancer cases are increasing due to the adoption of alcohol, western lifestyle, smoking, and poor diet choice. Thus in turn propel the cancer segment growth.

Erythropoietin Drugs Market-Competitive Landscape:

The increasing demand for erythropoietin drugs thus increases the market growth globally. Additionally, market players are focusing on new product launches, partnerships, joint ventures, collaborations, and regional growth. Moreover, an increase in anemia in cancer patients boosted the erythropoietin drug market growth. Furthermore, strategies used by market players to strengthen and expand their business include R&D spending, mergers & acquisitions, and distribution channel development. For instance, in March 2022, Zydus Lifesciences a company received the new drug approval for Oxemia (Desidustat). Additionally, it is a first-of-its-kind oral treatment for anemia associated with chronic kidney disease(CKD), from the Drugs Controller General of India (DCGI).

Key features of the study:

This proposed research study on erythropoietin drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for erythropoietin drugs market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the erythropoietin drugs market.

Impact of COVID-19 on erythropoietin drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on erythropoietin drugs market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the erythropoietin drugs market, we have also included competitive landscape and key innovator analysis for the Erythropoietin Drugs Market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the erythropoietin drugs market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global erythropoietin drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ERYTHROPOIETIN DRUGS MARKET KEY PLAYERS

  • AstraZeneca (U.K.)
  • Lupin (India)
  • Bristol-Myers Squibb Company (U.S.)
  • Endo International plc (Ireland)
  • JCR Pharmaceuticals Co., Ltd (Japan)
  • Pfizer Inc (U.S.)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Sun Pharmaceutical Industries Ltd (India)
  • Dr. Reddy's Laboratories Ltd (India)
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • Cipla Inc (India)
  • Shanghai Dahua Pharmaceutical Co., Ltd (China)

GLOBALERYTHROPOIETIN DRUGS MARKET, BY TYPE

  • Biologics
  • Biosimilars

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY PRODUCT

  • Erythropoietin
  • Darbepoetin-alfa

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY APPLICATION

  • Cancer
  • Renal Diseases
  • Neurology
  • Others

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Erythropoietin Drugs Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Erythropoietin Drugs Market Snippet by Type
    • 2.1.2. Erythropoietin Drugs Market Snippet by Product
    • 2.1.3. Erythropoietin Drugs Market Snippet by Application
    • 2.1.4. Erythropoietin Drugs Market Snippet by Country
    • 2.1.5. Erythropoietin Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Erythropoietin Drugs Key Market Trends

  • 3.1. Erythropoietin Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Erythropoietin Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Erythropoietin Drugs Market Opportunities
  • 3.4. Erythropoietin Drugs Market Future Trends

4. Erythropoietin Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Erythropoietin Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Erythropoietin Drugs Market Landscape

  • 6.1. Erythropoietin Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Erythropoietin Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
    • 7.1.2. Biologics
    • 7.1.3. Biosimilars

8. Erythropoietin Drugs Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022&2030 (%)
    • 8.1.2. Erythropoietin
    • 8.1.3. Darbepoetin-alfa

9. Erythropoietin Drugs Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 9.1.2. Cancer
    • 9.1.3. Renal Diseases
    • 9.1.4. Neurology
    • 9.1.5. Others

10. Erythropoietin Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Erythropoietin Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Erythropoietin Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Erythropoietin Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Erythropoietin Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Erythropoietin Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Erythropoietin Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca (U.K.)
    • 11.2.2. Lupin (India)
    • 11.2.3. Bristol-Myers Squibb Company (U.S.)
    • 11.2.4. Endo International plc (Ireland)
    • 11.2.5. JCR Pharmaceuticals Co., Ltd (Japan)
    • 11.2.6. Pfizer Inc (U.S.)
    • 11.2.7. Teva Pharmaceutical Industries Ltd (Israel)
    • 11.2.8. Sun Pharmaceutical Industries Ltd (India)
    • 11.2.9. Dr. Reddy's Laboratories Ltd (India)
    • 11.2.10. Mylan N.V. (U.S.)
    • 11.2.11. Novartis AG (Switzerland)
    • 11.2.12. Cipla Inc (India)
    • 11.2.13. Shanghai Dahua Pharmaceutical Co., Ltd (China)

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us